What are the contraindications for Nurtec?
NURTEC ODT is contraindicated in patients with a history of hypersensitivity reaction to rimegepant, NURTEC ODT, or any of its components. Delayed serious hypersensitivity has occurred [see Warnings and Precautions (5.1)].
What is contraindicated with rifampin?
(See CONTRAINDICATIONS.) When rifampin is given concomitantly with other hepatotoxic medications such as halothane or isoniazid, the potential for hepatotoxicity is increased. The concomitant use of rifampin and halothane should be avoided.
What are the contraindications of propylthiouracil?
Propylthiouracil is contraindicated in patients who have demonstrated hypersensitivity to the drug or any of the other product components. Liver injury resulting in liver failure, liver transplantation, or death, has been reported with propylthiouracil therapy in adult and pediatric patients.
Can you take Nurtec if you have high blood pressure?
Does Nurtec ODT increase blood pressure? No, Nurtec ODT doesn’t increase blood pressure. This side effect wasn’t reported in studies of the drug. Certain other drugs used to treat or prevent migraine can increase blood pressure.
What drugs interact with Nurtec?
Most frequently checked interactions
- Aimovig (erenumab)
- Emgality (galcanezumab)
What is a common side effect of rifampin?
Upset stomach, heartburn, nausea, menstrual changes, or headache may occur. If any of these effects last or get worse, inform your doctor promptly. This medication may cause urine, sweat, saliva, or tears to change color (yellow, orange, red, or brown).
What is Rifabon used for?
Rifampin is an antibiotic that is used to treat or prevent tuberculosis (TB). Rifampin may also be used to reduce certain bacteria in your nose and throat that could cause meningitis or other infections.
Is PTU contraindicated in pregnancy?
Both methimazole (MMI) and propylthiouracil (PTU) may be used during pregnancy; however, PTU is preferred in the first trimester and should be replaced by MMI after this trimester. Choanal and esophageal atresia of fetus in MMI-treated and maternal hepatotoxicity in PTU-treated pregnancies are of utmost concern.